2m 2m 2m 2m 2m 2m 2m
VIRIDIAN THERAPT (VRDN)
NASDAQ
$20.74-$0.50 (-2.38%)
Price as of Sep 11, 2026 7:54 PM EDT- $2.4BMarket Cap
- 12.56%1-Year Change
- BiotechnologyIndustry
VIRIDIAN THERAPT (VRDN)
$20.74-$0.50 (-2.38%)
VRDN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.24 | ||
Change | -$1.05 (-4.71%) | ||
Open | $22.48 | ||
High | $22.70 | ||
Low | $21.18 | ||
Previous Close | $22.29 | ||
Volume | 944,077 | ||
30-Day Average Volume | 1,256,976 | ||
1-Week Change | -7.33% | ||
1-Month Change | -7.53% | ||
1-Year Change | 12.56% | ||
3-Year Change | 18.86% | ||
5-Year Change | 73.25% | ||
Fundamentals | |||
Shares Outstanding | 113.3M | ||
Total Assets | $1.1B | ||
Market Cap | $2.4B | ||
Enterprise Value | $2.6B | ||
Period: QTR TTM FY | |||
Revenue | $233,000.00 | ||
Net Income | -$127.1M | ||
Free Cash Flow | -$106.6M | ||
EBIT | -$127.1M | ||
EBITDA | -$127.0M | ||
Net Working Capital | $1.0B | ||
EPS | -$1.05 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | 11,147 | ||
P/B | 4 | ||
P/E | -20 | ||
PEG | 1 | ||
Price/Free Cash Flow | -23 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 11/13/2020 | ||
Earnings & Revenue